| Product NDC: | 0173-0260 |
| Proprietary Name: | LANOXIN |
| Non Proprietary Name: | digoxin |
| Active Ingredient(s): | 250 ug/mL & nbsp; digoxin |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0173-0260 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA009330 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19851001 |
| Package NDC: | 0173-0260-10 |
| Package Description: | 10 AMPULE in 1 BOX (0173-0260-10) > 2 mL in 1 AMPULE |
| NDC Code | 0173-0260-10 |
| Proprietary Name | LANOXIN |
| Package Description | 10 AMPULE in 1 BOX (0173-0260-10) > 2 mL in 1 AMPULE |
| Product NDC | 0173-0260 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | digoxin |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19851001 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | DIGOXIN |
| Strength Number | 250 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |